Paxman Coolers launch next-generation scalp coolers for reducing hair loss during
16 November 2009
Huddersfield-based Paxman Coolers are launching their
next-generation NPAX1 scalp cooler at Medica in Dusseldorf this week.
Scalp coolers provide cancer patients with the best possible chance of
retaining their hair whilst undergoing chemotherapy treatment.
The loss of hair during cancer treatments is a traumatic and
psychologically devastating side effect and a constant reminder of the
Paxman’s cooling caps aim to minimise patient distress with figures
showing that on average 70-90% of patients who use the system do not
require a wig.
Made from lightweight, silicone tubing, the Paxman scalp cooling cap
is soft and flexible creating a snug yet comfortable cap during
Moulding to all head shapes and sizes, the specially developed liquid
coolant passes through the cap extracting heat from the patient's scalp,
ensuring the scalp remains at an even, constant temperature, minimising
The caps are worn 30 minutes before the start of chemotherapy, during
the treatment itself and for a period of time after infusion of the
chemotherapy depending on the toxicity of the drugs.
With straightforward programming and controls, including recommended
cooling time guides, the new generation cooling cap system is not only
effective, but uncomplicated.
The cap is connected to a cutting-edge and easy-to-use refrigeration
system which uses up-to-the-minute touch screen display, and simple
switch operation, making it easy for both the patient and staff to
Managing Director Glenn Paxman is hoping Medica will allow the
company to expand their links throughout the world: “Medica will allow
us to platform our products on an international stage and establish
links with potential business partners from across the globe; enabling
us to expand on our already buoyant overseas market.”